Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Valeria I. Segatori"'
Autor:
Alejandra M. Scursoni, Laura Galluzzo, Sandra Camarero, Jessica Lopez, Fabiana Lubieniecki, Claudia Sampor, Valeria I. Segatori, Mariano R. Gabri, Daniel F. Alonso, Guillermo Chantada, María Teresa G. de Dávila
Publikováno v:
Clinical and Developmental Immunology, Vol 2011 (2011)
The N-glycolylated ganglioside NeuGc-GM3 has been described in solid tumors such as breast carcinoma, nonsmall cell lung cancer, and melanoma, but is usually not detected in normal human cells. Our aim was to evaluate the presence of NeuGc-GM3 in ped
Externí odkaz:
https://doaj.org/article/419bb88c1b654ec0941352d0469db38a
Autor:
Marcelo David Guthmann, Cecilia eVenier, Darien eToledo, Valeria I Segatori, Daniel F Alonso, Leonardo eFainboim, Ana María eVázquez, Hector eOstrowski
Publikováno v:
Frontiers in Immunology, Vol 3 (2013)
Racotumomab is a murine anti-idiotype cancer vaccine targeting NeuGcGM3 on melanoma, breast and lung cancer. In order to characterize the immunogenicity of alum-adsorbed racotumomab in a non-clinical setting, Leghorn chickens were immunized in dose l
Externí odkaz:
https://doaj.org/article/57222d0a708e4394ac924c24ad998bd8
Autor:
Valeria I, Segatori, Laura L, Otero, Luis Enrique, Fernandez, Daniel E, Gomez, Daniel F, Alonso, Mariano R, Gabri
Publikováno v:
In vivo (Athens, Greece). 26(4)
Cancer vaccines are designed to modulate immunological responses against tumor cells through the presentation of tumor antigens.The mouse mRNA of the cytidine monophospho-N-acetylneuraminic acid hydroxylase (Cmah) gene, the enzyme that catalyzes the
Publikováno v:
Frontiers in Oncology, Vol 2 (2012)
N-glycolylneuraminic acid (NeuGc) is a sialic acid molecule usually found in mammalian cells as terminal constituents of different membrane glycoconjugates such as gangliosides. The NeuGcGM3 ganglioside has been described as a tumor antigen for non-s
Externí odkaz:
https://doaj.org/article/b39bd38f3882498b9764b3e7a0431b46